# Therapeutic Option for Hepatitis B and C: a French Cohort

> **NCT01953458** · — · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 20902 (actual)

## Conditions studied

- Viral Hepatitis B
- Viral Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01953458
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08-06
- **Primary completion:** 2024-12
- **Final completion:** 2024-12-31
- **Target enrollment:** 20902 (ACTUAL)
- **Last updated:** 2023-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01953458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01953458, "Therapeutic Option for Hepatitis B and C: a French Cohort". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01953458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*